EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Extracellular Vesicles Secreted by Cancer‐Associated Fibroblasts Drive Non‐Invasive Cancer Cell Progression to Metastasis via TGF‐β Signalling Hyperactivation

Adilson Fonseca Teixeira iD, Yanhong Wang, Josephine Iaria, Peter Ten Dijke iD, Hong-Jian Zhu

Journal of Extracellular Vesicles · 2025

DOI: 10.1002/jev2.70055 ↗

At a glance

Journal article in Journal of Extracellular Vesicles, 2025. Written by Adilson Fonseca Teixeira and 4 co-authors. Institution: Department of Surgery (The Royal Melbourne Hospital), The University of Melbourne, Parkville, Victoria, Australia. Major MEDLINE topics: Extracellular Vesicles, Cancer-Associated Fibroblasts, Transforming Growth Factor beta, Neoplasms. Cited 18 times so far (Crossref); 75 references. The full text is freely available (open access, CC BY 4.0). Funded by: Friends of the Royal Melbourne Hospital Neurosciences Foundation, National Health and Medical Research Council, Cancer Genomics Centre.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Metastasis is the leading cause of cancer‐related deaths. Cancer‐associated fibroblasts (CAFs) are abundant components within the tumour microenvironment, playing critical roles in metastasis. Although increasing evidence supports a role for small extracellular vesicles (sEVs) in this process, their precise contribution and molecular mechanisms remain unclear, compromising the development of antimetastatic therapies. Here, we establish that CAF‐sEVs drive metastasis by mediating CAF‐cancer cell interaction and hyperactivating TGF‐β signalling in tumour cells. Metastasis is abolished by genetically targeting CAF‐sEV secretion and consequent reduction of TGF‐β signalling in cancer cells. Pharmacological treatment with dimethyl amiloride (DMA) decreases CAFs’ sEV secretion, reduces TGF‐β signalling levels in tumour cells and abrogates metastasis and tumour self‐seeding. This work defines a new mechanism required by CAFs to drive cancer progression, supporting the therapeutic targeting of EV trafficking to disable the driving forces of metastasis.

Subjects

MeSH terms (MEDLINE)

Extracellular VesiclesCancer-Associated FibroblastsTransforming Growth Factor betaNeoplasmsHumansSignal TransductionNeoplasm MetastasisMiceAnimalsDisease ProgressionCell Line, TumorTumor MicroenvironmentFemale

Author keywords

TGF‐βcancer‐associated fibroblastscirculating tumour cellsextracellular vesiclesmetastasistherapytumour microenvironment

Substances

Transforming Growth Factor beta

Authors and institutions

  • Department of Surgery (The Royal Melbourne Hospital), The University of Melbourne, Parkville, Victoria, Australia.
  • Huagene Institute, Kecheng Science and Technology Park, Nanjing, Jiangsu, China.
  • Department of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.

ORCID profiles: Adilson Fonseca Teixeira, Peter Ten Dijke

Funding

  • Friends of the Royal Melbourne Hospital Neurosciences Foundation
  • National Health and Medical Research Council
  • Cancer Genomics Centre

Cite

APA

Teixeira, A. F., Wang, Y., Iaria, J., Ten Dijke, P., & Zhu, H. J. (2025). Extracellular Vesicles Secreted by Cancer‐Associated Fibroblasts Drive Non‐Invasive Cancer Cell Progression to Metastasis via TGF‐β Signalling Hyperactivation. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70055

Vancouver

Teixeira AF, Wang Y, Iaria J, Ten Dijke P, Zhu HJ. Extracellular Vesicles Secreted by Cancer‐Associated Fibroblasts Drive Non‐Invasive Cancer Cell Progression to Metastasis via TGF‐β Signalling Hyperactivation. Journal of Extracellular Vesicles. 2025. doi:10.1002/jev2.70055

BibTeX
@article{Teixeira2025,
  author = {Teixeira, Adilson Fonseca and Wang, Yanhong and Iaria, Josephine and Ten Dijke, Peter and Zhu, Hong-Jian},
  title = {Extracellular Vesicles Secreted by Cancer‐Associated Fibroblasts Drive Non‐Invasive Cancer Cell Progression to Metastasis via TGF‐β Signalling Hyperactivation},
  journal = {Journal of Extracellular Vesicles},
  year = {2025},
  doi = {10.1002/jev2.70055}
}
Start for free →